Skip to main content
SpringerLink
Log in
Book cover

Intraepithelial Neoplasia pp 170–216Cite as

Intraepithelial neoplasia of the breast

  • Chapter

  • 385 Accesses

Abstract

Hyperplastic lesions of the breast may be categorized histopathologically as either ductal or lobular. The nomenclature of lobular intraepithelial neoplasia (LIN) and ductal intraepithelial neoplasia (DIN) have recently been preferred. LIN includes atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) deriving from the terminal duct-lobular unit (TDLU) and showing a discohesive small-cell hyperplasia with or without Pagetoid extension into terminal ducts. Three grades as LIN1, LIN2 and LIN3 based on the extent and degree of cell proliferation and/or cytological features have been recommended. Ductal intraepithelial neoplasia (DIN) has diverse cytological and architectural features distinct from LIN, not only morphologically, but also in clinical significance and treatment. By definition, they originate from the TDLU and are confined to the mammary duct system, most often involving small-to-medium sized ducts, less often large or lactiferous ducts. Ductal intraepithelial neoplasia (DIN) include the lesions of usual epithelial hyperplasia (UDH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) and flat epithelial atypia (FEA).

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Parkin DM, Bray F, Ferlay J et al (2005) Global Cancer Statistics, 2002 CA Cancer J Clin 55:74–108

    Article  PubMed  Google Scholar 

  2. Haagensen CD, Lane N, Lattes R et al (1978) Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 42:737–769

    Article  PubMed  CAS  Google Scholar 

  3. Page DL, Kidd TE, Jr Dupont WD et al (1991) Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 22:1232–1239

    Article  PubMed  CAS  Google Scholar 

  4. Page DL, Dupont WD, Rogers LW et al (1982) Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer 49:751–758

    Article  PubMed  CAS  Google Scholar 

  5. Page DL, Dupont WD, Rogers LW et al (1985) Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 55:2698–2708

    Article  PubMed  CAS  Google Scholar 

  6. Van de Vijver MJ, Peterse H (2003) The diagnosis and management of pre-invasive breast disease: Pathological diagnosis-problems with existing classifications. Breast Cancer Res 5:269–275

    Article  PubMed  Google Scholar 

  7. Page DL, Dupont WD, Rogers LW (1986) Breast cancer risk of lobular-based hyperplasia after biopsy: “ductal” pattern lesions. Cancer Detect Prev 9:441–448

    PubMed  CAS  Google Scholar 

  8. Page DL, Dupont WD, Rogers LW et al (1995) Continued local recurrence of carcinoma 15–25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 76:1197–1200

    Article  PubMed  CAS  Google Scholar 

  9. Page DL, Dupont WD, Rogers LW (1988) Ductal involvement by cells of atypical lobular hyperplasia in the breast: a long-term follow-up study of cancer risk. Hum Pathol 19:201–207

    Article  PubMed  CAS  Google Scholar 

  10. Marshall LM, Hunter DJ, Connolly JL et al (1997) Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 6:297–301

    PubMed  CAS  Google Scholar 

  11. Bratthauer GL, Tavassoli FA (2004) Assessment of lesions coexisting with various grades of ductal intraepithelial neoplasia of the breast. Virchows Arch 444:340–344

    Article  PubMed  Google Scholar 

  12. Fadare O, Dadmanesh F, Alvarado-Cabrero I et al (2006) Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: A clinicopathologic study of 18 cases. Am J Surg Pathol 30:1445–1453

    Article  PubMed  Google Scholar 

  13. Tavassoli FA, Devilee P (2003) WHO classification of tumours Pathology & Genetics, tumors of the breast and female genital organs, LARC Press, Lyon

    Google Scholar 

  14. Crisi GM, Mandavilli S, Cronin E et al (2003) Invasive mammary carcinoma after immediate and short-term follow-up for lobular neoplasia on core biopsy. Am J Surg Pathol 27:325–333

    Article  PubMed  Google Scholar 

  15. Middleton LP, Grant S, Stephens T et al (2003) Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised? Mod Pathol 16:120–129

    Article  PubMed  Google Scholar 

  16. Sneige N, Wang J, Baker BA et al (2002) Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Pathol 15:1044–1050

    Article  PubMed  Google Scholar 

  17. Lavoué V, Graesslin O, Classe JM et al (2007) Management of lobular neoplasia diagnosed by core needle biopsy: study of 52 biopsies with follow-up surgical excision. Breast 16:533–539

    Article  PubMed  Google Scholar 

  18. Hanby AM, Hughes TA (2008) In situ and invasive lobular neoplasia of the breast. Histopathology 52:58–66

    PubMed  CAS  Google Scholar 

  19. Bratthauer GL, Tavassoli FA (2002) Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch 440:134–138

    Article  PubMed  Google Scholar 

  20. Lerwill MF (2004) Current practical applications of diagnostic immunohistochemistry in breast pathology. Am J Surg Pathol 28:1076–1091

    Article  PubMed  Google Scholar 

  21. Bratthauer GL, Monifar F, Stamatakos MD et al (2002) Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias. Hum Pathol 33:620–627

    Article  PubMed  CAS  Google Scholar 

  22. Perrone G, Zagami M, Santini D et al (2007) COX-2 expression in lobular in situ neoplasia of the breast: correlation with histopathological grading system according to the Tavassoli classification. Histopathology 51:33–39

    Article  PubMed  CAS  Google Scholar 

  23. Reis-Filho JS, Lakhani SR (2003) The diagnosis and management of pre-invasive breast disease: Genetic alterations in pre-invasive lesions. Breast Cancer Res 5:313–319

    Article  PubMed  CAS  Google Scholar 

  24. Nayar R, Zhuang Z, Merino MJ et al (1997) Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction. Hum Pathol 28:277–282

    Article  PubMed  CAS  Google Scholar 

  25. Vos CB, Cleton-Jansen AM, Berx G et al (1997) E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 76:1131–1133

    PubMed  CAS  Google Scholar 

  26. Berx G, Cleton-Jansen AM, Nollet F et al (1995) E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 14:6107–6115

    PubMed  CAS  Google Scholar 

  27. Jacobs TW, Pliss N, Kouria G et al (2001) Carcinomas in situ of the breast with indeteminate features: role of E-cadherin staining in categorization. Am J Surg Pathol 25:229–236

    Article  PubMed  CAS  Google Scholar 

  28. Maluf HM, Swanson PE, Koerner FC (2001) Solid low-grade in situ carcinoma of the breast: role of associated lesions and E-cadherin in differential diagnosis. Am J Surg Pathol 25:237–244

    Article  PubMed  CAS  Google Scholar 

  29. Tavassoli FA (1998) Ductal carcinoma in situ: introduction of the concept of ductal intraepithelial neoplasia. Mod Pathol 11:140–154

    PubMed  CAS  Google Scholar 

  30. Tavassoli FA, Norris HJ (1990) A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer 65:518–529

    Article  PubMed  CAS  Google Scholar 

  31. Schnitt SJ (2003) The diagnosis and management of pre-invasive breast disease: Flat epithelial atypia classification, pathologic features and clinical significance. Breast Cancer Res 5:263–268

    Article  PubMed  Google Scholar 

  32. Fraser JL, Raza S, Chorny K et al (1998) Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications. Am J Surg Pathol 22:1521–1527

    Article  PubMed  CAS  Google Scholar 

  33. Pinder SE, Ellis IO (2003) The diagnosis and management of pre-invasive breast disease: Ductal carcinoma in situ (DCIS) and atypical ductal hyperlasia (ADH) current definitions and classification. Breast Cancer Res 5:254–257

    Article  PubMed  Google Scholar 

  34. Eusebi V, Feudale E, Foschini MP et al (1994) Long-term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol 11:223–235

    PubMed  CAS  Google Scholar 

  35. Page DL, Dupont WD, Rogers LW et al (1982) Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer 49:751–758

    Article  PubMed  CAS  Google Scholar 

  36. Ernster VJ, Barclay J, Kerlikowske K et al (2000) Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch Intern Med 160:953–958

    Article  PubMed  CAS  Google Scholar 

  37. Eusebi V, Feudale E, Foschini MP et al (1994) Long-term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol 11:223–235

    PubMed  CAS  Google Scholar 

  38. Tavassoli FA (2001) Ductal intraepithelial neoplasia of the breast. Virchows Arch 438:221–227

    Article  PubMed  CAS  Google Scholar 

  39. Lagios MD, Margolin FR, Westdahl PR et al (1989) Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 63:618–624

    Article  PubMed  CAS  Google Scholar 

  40. Farshid G, Moinfar F, Meredith DJ et al (2001) Spindle cell ductal carcinoma in situ. An unusual variant of ductal intra-epithelial neoplasia that simulates ductal hyperplasia or a myoepithelial proliferation. Virchows Arch 439:70–77

    Article  PubMed  CAS  Google Scholar 

  41. Dabbs DJ, Chivukula M, Carter G et al (2006) Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile. Mod Pathol 19:1506–1511

    Article  PubMed  CAS  Google Scholar 

  42. Tsang WY, Chan JK (1996) Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics. Am J Surg Pathol 20:921–943

    Article  PubMed  CAS  Google Scholar 

  43. Tan PH, Lui GG, Chiang G et al (2004) Ductal carcinoma in situ with spindle cells: a potential diagnostic pitfall in the evaluation of breast lesions. Histopathology 45:343–351

    Article  PubMed  CAS  Google Scholar 

  44. Scott MA, Lagios MD, Axelsson K et al (1997) Ductal carcinoma in situ of the breast: reproducibility of histological subtype analysis. Hum Pathol 28:967–973

    Article  PubMed  CAS  Google Scholar 

  45. National Coordinating Group for Breast Screening Pathology (1995) Pathology Reporting in Breast Cancer Screening. NHSBSP Publications, Sheffield

    Google Scholar 

  46. Holland R, Peterse JL, Millis RR et al (1994) Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol 11:167–180

    PubMed  CAS  Google Scholar 

  47. Khan QJ, Kimler BF, Clark J et al (2005) Ki-67 expression in benign breast ductal cells obtained by random periareolar fine needle aspiration. Cancer Epidemiol Biomarkers Prev 14:786–789

    Article  PubMed  CAS  Google Scholar 

  48. Bobrow LG, Happerfield LC, Gregory WM et al (1995) Ductal carcinoma in itu: assessment of necrosis and nuclear morphology and their association with biological markers. J Pathol 176:333–341

    Article  PubMed  CAS  Google Scholar 

  49. Hieken TJ, Cheregi J, Farolan M et al (2007) Predicting relapse in ductal carcinoma in situ patients: an analysis of biologic markers with long-term follow-up. Am J Surg 194:504–506

    Article  PubMed  Google Scholar 

  50. Diallo R, Rody A, Jackisch C et al (2006) C-KIT expression in ductal carcinoma in situ of the breast: co-expression with HER-2/neu. Hum Pathol 37:205–211

    Article  PubMed  CAS  Google Scholar 

  51. Steinman S, Wang J, Bourne P et al (2007) HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast. Ann Clin Lab Sci 37:127–134

    PubMed  CAS  Google Scholar 

  52. Lakhani SR (1999) The transition from hyperplasia to invasive carcinoma of the breast. J Pathol 187:272–278

    Article  PubMed  CAS  Google Scholar 

  53. Moinfar F, Man YG, Bratthauer GL et al (2000) Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type (“clinging ductal carcinoma in situ”): a simulator of normal mammary epithelium. Cancer 88:2072–2081

    Article  PubMed  CAS  Google Scholar 

  54. Lakhani SR, Collins N, Stratton MR et al (1995) Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p. J Clin Pathol 48:611–615

    Article  PubMed  CAS  Google Scholar 

  55. Schnitt SJ (2003) Benign breast disease and breast cancer risk: morphology and beyond. Am J Surg Pathol 27:836–841

    Article  PubMed  Google Scholar 

  56. Datrice N, Narula N, Maggard M et al (2007) Do breast columnar cell lesions with atypia need to be excised? Am Surg 73:984–986

    PubMed  Google Scholar 

  57. Collins LC, Achacoso NA, Nekhlyudov L et al (2007) Clinical and pathologic features of ductal carcinoma in situ associated with the presence of flat epithelial atypia: an analysis of 543 patients. Mod Pathol 20:1149–1155

    Article  PubMed  Google Scholar 

  58. Leibl S, Regitnig P, Moinfar F (2007) Flat epithelial atypia (DIN 1 a, atypical columnar change): an underdiagnosed entity very frequently coexisting with lobular neoplasia. Histopathology 50:859–865

    Article  PubMed  CAS  Google Scholar 

  59. Bijker N, Peterse JL, Duchateau L et al (2001) Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 19:2263–2271

    PubMed  CAS  Google Scholar 

  60. Marshall LM, Hunter DJ, Connolly JL et al (1997) Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 6:297–301

    PubMed  CAS  Google Scholar 

  61. Purushotham AD (2003) The diagnosis and management of pre-invasive breast disease: problems associated with management of pre-invasive lesions. Breast Cancer Res 5:309–312

    Article  PubMed  Google Scholar 

  62. West JG, Qureshi A, Liao SY et al (2007) Multidisciplinary management of ductal carcinoma in situ: a 10-year experience. Am J Surg 194:532–534

    Article  PubMed  Google Scholar 

  63. EORTC Breast Cancer Cooperative Group, EORTC Radiotherapy Group, Bijker N et al (2006) Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853-a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24:3381–3387

    Article  PubMed  Google Scholar 

  64. Schouten van der Velden AP, van Vugt R, Van Dijck JA et al (2007) Local recurrences after different treatment strategies for ductal carcinoma in situ of the breast: a population-based study in the East Netherlands. Int J Radiat Oncol Biol Phys 69:703–710

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, China

    Guofeng Wang M.D.

  2. Department of Pathology, the First Affiliated Hospital, School of Medicine, Zhejiang University, China

    Zhaoming Wang M.D.

Authors
  1. Guofeng Wang M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhaoming Wang M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. School of Medicine, Zhejiang University, 310058, Hangzhou, China

    Maode Lai

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Higher Education Press, Beijing and Springer-Verlag GmbH Berlin Heidelberg

About this chapter

Cite this chapter

Wang, G., Wang, Z. (2009). Intraepithelial neoplasia of the breast. In: Lai, M. (eds) Intraepithelial Neoplasia. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-85453-1_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-85453-1_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-85452-4

  • Online ISBN: 978-3-540-85453-1

Publish with us

Policies and ethics

Search

Navigation